http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Azathioprine에 반응을 보인 류마티양 관절염에 의한 경막염(Pachymeningitis)1예
배광봉,이정호,이정찬,곽상혁,강정현,김철희,김현수,김종숙,조덕연,김삼용 충남대학교 의과대학 지역사회의학연구소 1999 충남의대잡지 Vol.26 No.1
Rheumatoid arthritis frequently involves the cervical spine and may lead to neurologic impairement. However, direct involvement of CNS structures by inflammatory cells has been reported infrequently. The prevalence of this complication of rheumatoid arthritis is unknown. Inflammatory CNS involvement in rheumatoid arthritis reportedly occurs in the setting of longstanding, active, erosive articular disease and is accompanied by extracranial and extraspinal nodules and vasculitis. This is diagnosed by radiologic finding of CNS nodules or meningeal thickening and by biopsy or autopsy. Treatment with corticosteroid, cytotoxic agent or surgical decompression is helpful. But the majority of patients die within several months of onset of neurologic symptom. Recently, we experienced a case of pachymeningitis caused by rheumatoid arthritis, which resolved repeatedly with azathioprine treatment.
김한성,최현준,주미,장선희,곽지은,김철남 인제대학교 2006 仁濟醫學 Vol.27 No.-
Typical serous cystadenoma of pancreas is formed by many microcysts, of which diameter are less than 2cm. Recently, rare variants are also reported as macrocystic, unicystic, or multicentric. Macrocystic serous cystadenoma is diffcult to differentiate from pseudocyst, mucinous cystadenoma and other cystic mass having macrocysts. As these lesions have different symptoms, methods of treatment, and prognoses, it is important to diagnose and treat correctly. We report 2 cases which diagnosed as macrocystic serous cystadenoma with stressing scarcity value and clinical importance.
주관절 외상과염에서 체외 충격파 치료의 누적 에너지량 효과
곽희철 ( Hee Chul Gwak ),최장석 ( Jang Suk Choi ),김창완 ( Chang Wan Kim ),김정한 ( Jung Han Kim ),조일제 ( Ill Je Jo ) 대한스포츠의학회 2010 대한스포츠의학회지 Vol.28 No.1
The aim of this study was to investigate the dose-related effects of extracorporeal shock wave therapy (ESWT) on the lateral epicondylitis of the elbow. Between March 2005 and March 2008, 66 patients who had been treated with extracorporeal shock wave therapy due to lateral epicondylitis of elbow formed the subjects. The subjects were divided into the 1st, 2nd and the 3rd treatment group and evaluated the clinical outcomes by visual analog scale (VAS) and a simple elbow test (SET) at immediate treatment, posttreatment 6 and 12 months, retrospectively. Changes in VAS score between the 2nd and 3rd treatment group and between the 1st and 3rd treatment group showed significant difference only at posttreatment 1 month group (p=0.001, 0.2, 0.1), (p=0.03, 0.08, 0.3), but Visual Analog Scale score at posttreatment 1 month showed no difference within the groups (p=1.0, 0.2, 0.07). SET within and between the groups showed significant difference at posttreatment 6 and 12 months (p<0.05).
요골 원위부 골절에서 수장측 잠김 금속판 제거술 후 임상적 평가
곽희철 ( Hee Chul Gwak ),김주용 ( Joo Yong Kim ),공규민 ( Gyu Min Kong ),김정원 ( Jung Won Kim ),곽재용 ( Jae Yong Kwak ),김동균 ( Dong Gyun Kim ) 대한골절학회 2014 대한골절학회지 Vol.27 No.1
목적: 수장 잠김 금속판으로 치료한 요골 원위부 골절에서 금속판 제거술 후의 임상적 평가에 대하여 분석하였다. 대상 및 방법: 인제대학교 부산백병원에서 2006년부터 2011년까지 요골 원위부 골절에 대해 수장 잠김 금속판을 이용한 관혈적정복술을 시행받은 150명, 162예 중, 금속판 제거 수술을 시행받은 34명, 36골절 증례에 대하여 후향적 분석을 시행하였다. 금속판 제거술 전, 후에 대하여 시각 통증 척도와 quick-disabilities of the arm, shoulder and hand (Q-DASH) 점수, 손목 운동 범위, 악력에 대해 평가를 시행하였다. 결과: 금속판 제거술을 시행한 주된 이유는 충분한 시기 경과 및 환자의 제거 원함이 가장 많았다. 평균 시각 통증 척도 점수는 수술 전 1.78, 수술 후 1.81이었고(p=0.64), Q-DASH 점수는 수술 전 30.02, 수술 후 38.46이었다(p<0.001). 술전 파악력 및 집기력은 각각 18.14 kg와 7.67 kg이었으며, 술 후에는 각각 15.27 kg와 6.94 kg였다(p=0.23). 결론: 수장 잠김 금속판을 이용한 요골 원위부 골절 치료 후의 금속판 제거술의 시행은 환자의 임상적, 사회 및 경제적 상황을 고려하여 신중하게 결정되어야 한다. Purpose: The purpose of this study is to evaluate the clinical outcomes after removing the volar locking plate for distal radius fracture. Materials and Methods: We reviewed retrospectively the medical records of 34 patients, 36 cases after removing the plates among 150 patients, with 162 cases that underwent open reduction and internal fixation using the volar locking plate between January 2006 and May 2011. We performed preoperative and postoperative clinical assessments using the quick-disabilities of the arm, shoulder and hand (Q-DASH), the visual analog scale (VAS) score, and the range of motion on wrist, grip and pinch power. Results: The major reason for plate removal was the time to remove the plate according to the fracture union and the patient`s demand without other specific complaints (28 cases). The mean preoperative VAS score was 1.78 and the mean postoperative VAS score 1.81 (p=0.64). The mean preoperative Q-DASH score was 30.02 and the mean postoperative Q-DASH score 38.46 (p<0.001). The mean preoperative grip and pinch power were 18.14 kg and 7.67 kg. The mean postoperative grip and pinch power were 15.27 kg and 6.94 kg (p=0.23). Conclusion: The removal of the volar locking plate for distal radius fracture should be decided by considering the patient`s clinical and socioeconomic conditions carefully.
Gwak, Ho-Shin,Park, Myung-Jin,Park, In-Chul,Woo, Sang Hyeok,Jin, Hyeon-Ok,Rhee, Chang Hun,Jung, Hee-Won American Association of Neurological Surgeons 2014 Journal of Neurosurgery Vol.121 No.6
<P>Local invasiveness of malignant glioma is a major reason for the failure of current treatments including surgery and radiation therapy. Tetraarsenic oxide (As4O6 [TAO]) is a trivalent arsenic compound that has potential anticancer and antiangiogenic effects in selected cancer cell lines at a lower concentration than arsenic trioxide (As2O3 [ATO]), which has been more widely tested in vitro and in vivo. The authors tried to determine the cytotoxic concentration of TAO in malignant glioma cell lines and whether TAO would show anti-invasive effects under conditions independent of cell death or apoptosis.</P>
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
Gwak, Ho-Shin,Yee, Gi Taek,Park, Chul-Kee,Kim, Jin Wook,Hong, Yong-Kil,Kang, Seok-Gu,Kim, Jeong Hoon,Seol, Ho Jun,Jung, Tae-Young,Chang, Jong Hee,Yoo, Heon,Hwang, Jeong-Hyun,Kim, Se-Hyuk,Park, Bong Ji The Korean Neurosurgical Society 2013 Journal of Korean neurosurgical society Vol.54 No.6
Objective : To evaluate the efficacy of temozolomide (TMZ) chemotherapy for recurrent anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA). Methods : A multi-center retrospective trial enrolled seventy-two patients with histologically proven AO/AOA who underwent TMZ chemotherapy for their recurrent tumors from 2006 to 2010. TMZ was administered orally (150 to 200 $mg/m^2/day$) for 5 days per 28 days until unacceptable toxicity occurred or tumor progression was observed. Results : TMZ chemotherapy cycles administered was median 5.3 (range, 1-41). The objective response rate was 24% including 8 cases (11%) of complete response and another 23 patients (32%) were remained as stable disease. Severe side effects (${\geq}$grade 3) occurred only in 9 patients (13%). Progression-free survival (PFS) of all patients was a median 8.0 months (95% confidence interval, 6.0-10.0). The time to recurrence of a year or after was a favorable prognostic factor for PFS (p<0.05). Overall survival (OS) was apparently differed by the patient's histology, as AOA patients survived a median OS of 18.0 months while AO patients did not reach median OS at median follow-up of 11.5 months (range 2.7-65 months). Good performance status of Eastern Cooperative Oncology Group 0 and 1 showed prolonged OS (p<0.01). Conclusion : For recurrent AO/AOA after surgery followed by radiation therapy, TMZ could be recommended as a salvage therapy at the estimated efficacy equal to procarbazine, lomustine, and vincristine (PCV) chemotherapy at first relapse. For patients previously treated with PCV, TMZ is a favorable therapeutic option as 2nd line salvage chemotherapy with an acceptable toxicity rate.
전이성 뇌종양 환자에서 원발 종양 가중치에 따른 생존율 분석
곽희근(Hee Keun Gwak),김우철(Woo Chul Kim),김헌정(Hun Jung Kim),박정훈(Jung Hoon Park),송창훈(Chang Hoon Song) 대한방사선종양학회 2009 Radiation Oncology Journal Vol.27 No.3
목 적: 전이성 뇌종양 환자에서 전뇌조사를 시행받은 160명의 환자를 대상으로 원발 종양 가중치에 따른 생존율을 후향적으로 분석해보고자 하였다. 대상 및 방법: 2002년부터 2008년 사이에 인하대병원에서 전이성 뇌종양으로 진단받은 암환자들 중 전뇌 조사 방사선 치료 30 Gy를 받은 160명의 환자를 대상으로 후향적으로 분석하였다. 원발성 종양이 유방암인 경우는 20명, 폐암인 경우는 103명이었다. 160명의 환자 중 척수 연수막 전이(leptomeningeal seeding) 환자를 제외한, 142명의 환자를 대상으로 예후 인자 및 Recursive Partitioning Aanalysis (RPA) 분류에 따른 생존율, 중앙생존기간과, RPA 분류에 원발 종양의 종류에 따라 가중치를 둔 새로운 Weighted Partitioning Analysis (WPA) 분류에 따른 생존율과 중앙생존기간을 분석하였고 RPA분류와 비교 분석하였다. 결 과: RPA분류에 의한 중앙생존기간은 분류 I (8명), 분류 II (76명), 분류 III (58명)가 각각 20.0개월, 10.0개월,3.0개월이었으며(p=0.003), WPA 분류의 경우에는 분류 I (3명), 분류 II (9명), 분류 III (70명), 분류 IV (60명)가 각각 36개월, 23.7개월, 10.9개월, 8.6개월로(p=0.001) RPA 분류보다 더 우위성을 보였다. 결 론: 새로운 예후 지표인 WPA 분류가 기존의 RPA 분류보다 전이성 뇌종양 환자에서 치료 방침을 결정함에 있어 도움을 줄 것으로 생각된다. Purpose: This study was performed to retrospectively analyze patient survival by weighting according to the primary tumor oncotype in 160 patients with brain metastasis and who underwent whole brain radiotherapy. Materials and Methods: A total of 160 metastatic brain cancer patients who were treated with whole brain radiotherapy of 30 Gy between 2002 and 2008 were retrospectively analyzed. The primary tumor oncotype of 20 patients was breast cancer, and that of 103 patients was lung cancer. Except for 18 patients with leptomeningeal seeding, a total of 142 patients were analyzed according to the prognostic factors and the Recursive Partitioning Analysis (RPA) class. Weighted Partitioning Analysis (WPA), with the weighting being done according to the primary tumor oncotype, was performed and the results were correlated with survival and then compared with the RPA Class. Results: The median survival of the patients in RPA Class I (8 patients) was 20.0 months, that for Class II (76 patients) was 10.0 months and that for Class III (58 patients) was 3.0 months (p<0.003). The median survival of patients in WPA Class I (3 patients) was 36 months, that for the patients in Class II (9 patients) was 23.7 months, that for the patients in Class III (70 patients) was 10.9 months and that for the patients in Class IV (60 patients) was 8.6 months (p<0.001). The WPA Class might have more accuracy in assessing survival, and it may be superior to the RPA Class for assessing survival. Conclusion: A new prognostic index, the WPA Class, has more prognostic value than the RPA Class for the treatment of patients with metastatic brain cancer. This WPA Class may be useful to guide the appropriate treatment of metastatic brain lesions.
추간판 탈출증 환자에서 미추 접근법으로 일측 경막외 카테터를 통한 스테로이드 주입 시 유효 용량에 관한 연구
신영희 ( Young Hee Shin ),김태형 ( Tae Hyeong Kim ),이석진 ( Seok Jin Lee ),이철중 ( Chul Joong Lee ),심우석 ( Woo Seok Sim ),곽미숙 ( Mi Sook Gwak ),김정수 ( Chung Soo Kim ),함태수 ( Tae Soo Hahm ),김명희 ( Myung Hee Kim ),조현성 대한마취과학회 2008 Korean Journal of Anesthesiology Vol.54 No.4